Trials / Completed
CompletedNCT04414189
Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Inflammatix · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will analyze HostDx Sepsis results from whole blood samples collected from patients with suspected sepsis or at risk for sepsis in the surgical ICU
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HostDx Sepsis | Blood collection for mRNA analysis |
Timeline
- Start date
- 2020-06-07
- Primary completion
- 2021-07-21
- Completion
- 2021-10-19
- First posted
- 2020-06-04
- Last updated
- 2021-12-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04414189. Inclusion in this directory is not an endorsement.